Ginkgo Bioworks Holdings (DNA) Income from Continuing Operations (2020 - 2026)

Ginkgo Bioworks Holdings has reported Income from Continuing Operations for 7 years, with the latest figure at 76059000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 8.7% year-over-year to 76059000.0; the trailing twelve-month figure through Mar 2026 stood at 297865000.0 (up 35.86% YoY), and the FY2025 full-year result was 312763000.0, up 42.83% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 76059000.0, up from 80751000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 56403000.0 in Q3 2024, with the low at 670570000.0 in Q2 2022.
• Historically, Income from Continuing Operations has averaged 231026176.47 across 5 years, with a median of 173078000.0 in 2022.
• The largest YoY upside for Income from Continuing Operations was 89.22% in 2022 against a maximum downside of 1131.22% in 2022.
• Ginkgo Bioworks Holdings' Income from Continuing Operations stood at 173078000.0 in 2022, then fell by 22.31% to 211694000.0 in 2023, then surged by 49.2% to 107534000.0 in 2024, then gained by 24.91% to 80751000.0 in 2025, then climbed by 5.81% to 76059000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 76059000.0 (Q1 2026), 80751000.0 (Q4 2025), and 80755000.0 (Q3 2025), per Business Quant data.